Published in JAMA on March 04, 1998
Health literacy and anticoagulation-related outcomes among patients taking warfarin. J Gen Intern Med (2006) 1.96
Key questions concerning paracetamol and NSAIDs for osteoarthritis. Ann Rheum Dis (2002) 1.64
Adverse interaction of warfarin and paracetamol: evidence from a post-mortem study. Eur J Clin Pharmacol (2009) 1.44
Acetaminophen and warfarin: undesirable synergy. JAMA (1998) 1.43
Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleeding. Clin Pharmacol Ther (2008) 1.30
Patterns and perceptions of complementary/alternative medicine among paediatricians and patients' mothers: a review of the literature. Eur J Pediatr (2003) 1.24
Drug interactions-information, education, and the British National Formulary. Br J Clin Pharmacol (2004) 1.12
Psychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin. J Gen Intern Med (2005) 0.99
Coagulation assessment with the new generation of oral anticoagulants. Emerg Med J (2015) 0.93
Alcohol intake and noncoronary cardiovascular diseases. Ann Epidemiol (2007) 0.92
Patient reported receipt of medication instructions for warfarin is associated with reduced risk of serious bleeding events. J Gen Intern Med (2008) 0.89
What drugs are our frail elderly patients taking? Do drugs they take or fail to take put them at increased risk of interactions and inappropriate medication use? Can Fam Physician (2001) 0.85
Paracetamol: a haemorrhagic risk factor in patients on warfarin. Br J Clin Pharmacol (2005) 0.84
Personalized versus non-personalized computerized decision support system to increase therapeutic quality control of oral anticoagulant therapy: an alternating time series analysis. BMC Health Serv Res (2004) 0.83
Correlates of alcohol-related discussions between older adults and their physicians. J Am Geriatr Soc (2010) 0.82
Anticoagulation control in the peri-hospitalization period. J Gen Intern Med (2007) 0.82
Effectiveness of warfarin among patients with cancer. J Gen Intern Med (2007) 0.81
Interaction between acetaminophen and warfarin in adults receiving long-term oral anticoagulants: a randomized controlled trial. Eur J Clin Pharmacol (2010) 0.81
Impact of Body Mass Index and Genetics on Warfarin Major Bleeding Outcomes in a Community Setting. Am J Med (2016) 0.78
Evaluating the impact of new anticoagulants in the hospital setting. Pharm Pract (Granada) (2011) 0.77
Effect of high-dose cranberry juice on the pharmacodynamics of warfarin in patients. Br J Clin Pharmacol (2010) 0.77
Analgesic use before and after oral anticoagulant initiation--a population-based study in Finland. Eur J Clin Pharmacol (2015) 0.77
Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction. J Am Heart Assoc (2017) 0.76
Acetaminophen and risk factors for excess anticoagulation with warfarin. JAMA (1998) 0.75
Acetaminophen and risk factors for excess anticoagulation with warfarin. JAMA (1998) 0.75
When the INR comes back too high. Can Fam Physician (1998) 0.75
What affects anticoagulation control in patients taking warfarin? Br J Gen Pract (2009) 0.75
Acetaminophen and risk factors for excess anticoagulation with warfarin. JAMA (1998) 0.75
Acetaminophen and risk factors for excess anticoagulation with warfarin. JAMA (1998) 0.75
Observational evidence for determining drug safety: Too high a pedestal. BMJ (2008) 0.75
Acetaminophen and risk factors for excess anticoagulation with warfarin. JAMA (1998) 0.75
Using highly variable warfarin dosing to identify patients at risk for adverse events. Thromb J (2011) 0.75
Factors influencing warfarin response in hospitalized patients. Saudi Pharm J (2015) 0.75
Analysis of potential interactions between warfarin and prescriptions in Estonian outpatients aged 50 years or more. Pharm Pract (Granada) (2012) 0.75
Predicting prolonged dose titration in patients starting warfarin. Pharmacoepidemiol Drug Saf (2016) 0.75
Adverse drug events associated with vitamin K antagonists: factors of therapeutic imbalance. Vasc Health Risk Manag (2013) 0.75
Acetaminophen and risk factors for excess anticoagulation with warfarin. JAMA (1998) 0.75
The risk factors associated with postoperative hemorrhage after tooth extraction: a multi-center retrospective study of patients receiving oral antithrombotic therapy. Oral Maxillofac Surg (2017) 0.75
Warfarin anticoagulation after congenital heart surgery at a large children's hospital. Pediatr Cardiol (2012) 0.75
A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med (1997) 24.87
Assessing health-related quality of life in patients with sciatica. Spine (Phila Pa 1976) (1995) 7.23
Screening for ovarian cancer: a pilot randomised controlled trial. Lancet (1999) 5.81
The clinical information value of the glycosylated hemoglobin assay. N Engl J Med (1984) 4.79
Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med (1999) 4.54
The Maine Lumbar Spine Study, Part III. 1-year outcomes of surgical and nonsurgical management of lumbar spinal stenosis. Spine (Phila Pa 1976) (1996) 4.11
The effect of enforcing tobacco-sales laws on adolescents' access to tobacco and smoking behavior. N Engl J Med (1997) 4.06
An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med (1996) 3.86
Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med (1994) 3.33
Surgical and nonsurgical management of lumbar spinal stenosis: four-year outcomes from the maine lumbar spine study. Spine (Phila Pa 1976) (2000) 3.09
Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA (1998) 3.03
National patterns in the treatment of smokers by physicians. JAMA (1998) 2.94
The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. Arch Intern Med (1991) 2.92
The Maine Lumbar Spine Study, Part II. 1-year outcomes of surgical and nonsurgical management of sciatica. Spine (Phila Pa 1976) (1996) 2.91
Antithrombotic therapy in atrial fibrillation. Chest (2001) 2.62
The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus. Am J Med (2001) 2.60
Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals. Arch Intern Med (2001) 2.51
Clinical inertia in the management of Type 2 diabetes metabolic risk factors. Diabet Med (2004) 2.42
The Quebec Task Force classification for Spinal Disorders and the severity, treatment, and outcomes of sciatica and lumbar spinal stenosis. Spine (Phila Pa 1976) (1996) 2.41
Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia? Arch Intern Med (1996) 2.29
Comparison of a disease-specific and a generic severity of illness measure for patients with community-acquired pneumonia. J Gen Intern Med (1995) 2.22
Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med (1999) 2.21
Comparison of time spent writing orders on paper with computerized physician order entry. Stud Health Technol Inform (2001) 2.18
Surgical and nonsurgical management of sciatica secondary to a lumbar disc herniation: five-year outcomes from the Maine Lumbar Spine Study. Spine (Phila Pa 1976) (2001) 2.17
Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Circulation (2000) 2.09
Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study. Am J Med (1990) 2.06
Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study. J Clin Epidemiol (1996) 2.03
Rationing intensive care--physician responses to a resource shortage. N Engl J Med (1983) 2.00
Long-term disability and return to work among patients who have a herniated lumbar disc: the effect of disability compensation. J Bone Joint Surg Am (2000) 1.95
Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. The Framingham Offspring Study. Ann Intern Med (1998) 1.95
The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass. JAMA (1991) 1.93
Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes (1997) 1.88
Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia. Am J Med (2000) 1.88
Risk factors for stroke in patients with nonrheumatic atrial fibrillation: a case-control study. Am J Med (1991) 1.85
Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA (2000) 1.83
Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database. Am J Med (1993) 1.83
The use of nicotine-replacement therapy by hospitalized smokers. Am J Prev Med (1999) 1.78
National patterns of warfarin use in atrial fibrillation. Arch Intern Med (1997) 1.75
Stroke prevention in atrial fibrillation. BMJ (1997) 1.74
Patients with syncope admitted to medical intensive care units. JAMA (1982) 1.74
Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin. Ann Intern Med (2001) 1.69
Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care (2001) 1.63
The relation between expectations and outcomes in surgery for sciatica. J Gen Intern Med (1999) 1.62
Standards of care for diabetes. Diabetes Care (1994) 1.59
Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): The NIDDM Patient Outcome Research Team. Am J Med (1997) 1.59
Recent national patterns of warfarin use in atrial fibrillation. Circulation (1998) 1.57
Understanding physician adherence with a pneumonia practice guideline: effects of patient, system, and physician factors. Arch Intern Med (2000) 1.56
Factors influencing serum CA125II levels in healthy postmenopausal women. Cancer Epidemiol Biomarkers Prev (2001) 1.55
Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial. Arch Intern Med (1998) 1.55
Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. Arch Intern Med (2000) 1.55
Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med (1997) 1.54
Screening for ovarian cancer. Ann Intern Med (1994) 1.53
The hospital admission decision for patients with community-acquired pneumonia. Results from the pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med (1997) 1.50
The hospital discharge decision for patients with community-acquired pneumonia. Results from the Pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med (1997) 1.44
Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med (1997) 1.40
The triage decision in pulmonary edema. J Gen Intern Med (1989) 1.40
The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is ... or is it? Lancet (1997) 1.40
Determinants of compliance with anticoagulation: A case-control study. Am J Med (1997) 1.40
Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Am J Med (1996) 1.38
Antithrombotic therapy in atrial fibrillation. Chest (1998) 1.38
Randomized trials of warfarin for atrial fibrillation. N Engl J Med (1992) 1.32
Preparation, stability, and in vitro performance of vesicles made with diblock copolymers. Biotechnol Bioeng (2001) 1.30
Efficacy of a smoking cessation program for hospital patients. Arch Intern Med (1998) 1.28
The Maine Lumbar Spine Study, Part I. Background and concepts. Spine (Phila Pa 1976) (1996) 1.27
Glycemic control in diabetes mellitus: have changes in therapy made a difference? Am J Med (1996) 1.26
Smoking by patients in a smoke-free hospital: prevalence, predictors, and implications. Prev Med (2000) 1.23
Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia. JAMA (1997) 1.23
Arterial blood gas and pulse oximetry in initial management of patients with community-acquired pneumonia. J Gen Intern Med (2001) 1.22
Preferences for home vs hospital care among low-risk patients with community-acquired pneumonia. Arch Intern Med (1996) 1.22
Measuring symptomatic and functional recovery in patients with community-acquired pneumonia. J Gen Intern Med (1997) 1.20
Preventing stroke in atrial fibrillation. Am Fam Physician (1997) 1.19
Retinopathy in older type II diabetics. Association with glucose control. Diabetes (1986) 1.18
Dipyridamole-thallium scanning in patients undergoing vascular surgery. Optimizing preoperative evaluation of cardiac risk. JAMA (1987) 1.17
National trends in the use of antibiotics by primary care physicians for adult patients with cough. Arch Intern Med (1998) 1.15
Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation. Br J Cancer (1999) 1.13
Stroke following coronary-artery bypass surgery. A case-control estimate of the risk from carotid bruits. N Engl J Med (1988) 1.13
Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes? Am J Med (1999) 1.12
Variations in antimicrobial use and cost in more than 2,000 patients with community-acquired pneumonia. Am J Med (1998) 1.09
Graphic presentation of computer-analyzed keratoscope photographs. Arch Ophthalmol (1987) 1.08
The uses of outcomes research for medical effectiveness, quality of care, and reimbursement in type II diabetes. Diabetes Care (1994) 1.07
Changing blood use in the AIDS era: the case of elective hip surgery. Transfusion (1994) 1.07
Quantifying the potential benefit of CA 125 screening for ovarian cancer. J Clin Epidemiol (1991) 1.07
Smoking cessation following admission to a coronary care unit. J Gen Intern Med (1991) 1.05
Prognosis of patients hospitalized with community-acquired pneumonia. Am J Med (1990) 1.04
Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening. BJOG (2000) 1.03
Decreased cognitive function in aging non-insulin-dependent diabetic patients. Am J Med (1984) 1.02
Change in physician knowledge and attitudes after implementation of a pneumonia practice guideline. J Gen Intern Med (1999) 1.02
Linkage of severity of experimental allergic encephalomyelitis to the rat major histocompatibility locus. J Immunol (1980) 1.02
Analysis of c-erbB-2 expression in breast carcinomas with clinical follow-up. Cancer Res (1989) 1.02
High prevalence of HIV infection among rural tea plantation residents in Kericho, Kenya. Epidemiol Infect (2007) 0.99